$1.7B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | RLAY Relay Therapeutics Inc | 12.0M | −29.4% | $225M | 13.4% |
| 2 | ELVN Enliven Therapeutics Inc | 3.3M | +0.0% | $166M | 9.9% |
| 3 | ALKS Alkermes Plc | 3.0M | −28.6% | $157M | 9.4% |
| 4 | COGT Cogent Biosciences Inc | 3.0M | +5.6% | $118M | 7.0% |
| 5 | AMLX Amylyx Pharmaceuticals Inc | 5.7M | +0.0% | $101M | 6.0% |
| 6 | DFTX Definium Therapeutics Inc | 2.0M | +0.0% | $94M | 5.6% |
| 7 | SYRE Spyre Therapeutics Inc | 846,786 | −55.7% | $75M | 4.5% |
| 8 | ANRO Alto Neuroscience Inc | 2.7M | +0.0% | $72M | 4.3% |
| 9 | TNGX Tango Therapeutics Inc | 2.2M | — | $70M | 4.2% |
| 10 | EYPT Eyepoint Inc | 4.6M | +62.8% | $66M | 3.9% |
| 11 | TYRA Tyra Biosciences Inc | 1.9M | −24.2% | $60M | 3.6% |
| 12 | DMRA Damora Therapeutics Inc | 1.9M | +0.0% | $50M | 3.0% |
| 13 | CLDX Celldex Therapeutics Inc New | 1.4M | −49.9% | $50M | 3.0% |
| 14 | PHVS Pharvaris N V | 1.4M | −25.7% | $49M | 2.9% |
| 15 | LBRX Lb Pharmaceuticals Inc | 1.5M | +0.0% | $49M | 2.9% |
| 16 | ASMB Assembly Biosciences Inc | 1.4M | +41.5% | $39M | 2.3% |
| 17 | EDIT Editas Medicine Inc | 8.9M | — | $29M | 1.7% |
| 18 | KYMR Kymera Therapeutics Inc | 250,000 | −66.7% | $29M | 1.7% |
| 19 | CATX Perspective Therapeutics Inc | 6.3M | +0.0% | $22M | 1.3% |
| 20 | IPSC Century Therapeutics Inc | 8.7M | +0.0% | $21M | 1.3% |
| 21 | ZURA Zura Bio Ltd | 3.2M | +0.0% | $19M | 1.1% |
| 22 | AVTX Avalo Therapeutics Inc | 1.0M | +110.8% | $19M | 1.1% |
| 23 | INFLARX NV Inflarx Nv | 7.3M | — | $16M | 1.0% |
| 24 | ANTX An2 Therapeutics Inc | 2.9M | +25.7% | $14M | 0.8% |
| 25 | NUVALENT INC Nuvalent Inc | 100,000 | −88.0% | $12M | 0.7% |
| 26 | SABS Sab Biotherapeutics Inc | 2.9M | −34.8% | $11M | 0.7% |
| 27 | IKT Inhibikase Therapeutics Inc | 5.4M | +0.0% | $11M | 0.7% |
| 28 | RLMD Relmada Therapeutics Inc | 1.4M | +124.8% | $10M | 0.6% |
| 29 | PEPG Pepgen Inc | 4.5M | +0.0% | $8M | 0.5% |
| 30 | RACC Research Alliance Corp Iii | 500,000 | — | $5M | 0.3% |
| 31 | HLXC Helix Acquisition Corp Iii | 500,000 | +0.0% | $5M | 0.3% |
| 32 | LONA Leonabio Inc | 464,398 | +0.0% | $4M | 0.3% |
| 33 | VTGN Vistagen Therapeutics Inc | 2.8M | — | $630,228 | 0.0% |